このアイテムのアクセス数: 2097

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
57_81.pdf1.74 MBAdobe PDF見る/開く
タイトル: 局所進行性膀胱癌に対するGemcitabine-Cisplatin療法中に発症した間質性肺炎の1例
その他のタイトル: A Case of Interstitial Pneumonia During Gemcitabine and Cisplatin Chemotherapy for Locally Advanced Bladder Cancer
著者: 松村, 英理  KAKEN_name
芦刈, 明日香  KAKEN_name
田崎, 新資  KAKEN_name
原永, 修作  KAKEN_name
豊里, 友常  KAKEN_name
安次嶺, 聡  KAKEN_name
町田, 典子  KAKEN_name
大城, 吉則  KAKEN_name
斎藤, 誠一  KAKEN_name
著者名の別形: Matsumura, Eiri
Ashikari, Asuka
Tasaki, Shinsuke
Haranaga, Syusaku
Toyosato, Tomotsune
Ashimine, Satoshi
Machida, Noriko
Oshiro, Yoshinori
Saito, Seiichi
キーワード: Drug-induced interstitial pneumonia
Gemcitabine
発行日: Feb-2011
出版者: 泌尿器科紀要刊行会
誌名: 泌尿器科紀要
巻: 57
号: 2
開始ページ: 81
終了ページ: 85
抄録: A 76-year-old woman received chemotherapy with gemcitabine and cisplatin (GC therapy) for local advanced bladder cancer. She suffered from dyspnea on day 19 during the first course of GC therapy. Both chest X-ray and computed tomography (CT) images revealed diffuse bilateral interstitial infiltrates. She was diagnosed as having drug-induced interstitial pneumonia. We identified gemcitabine as the causative agent based on the results of examinations (CT, X-ray, KL-6 level, drug lymphocyte stimulation test (DLST)). After three months of steroid therapy, her interstitial pneumonia was completely resolved on CT scans. Although gemcitabine-induced interstitial pneumonia is a rare adverse event, it should be considered a severe complication because delayed diagnosis and treatment can lead to a fatal outcome. Thus, early detection of drug-induced interstitial pneumonia is extremely important during GC therapy.
著作権等: 許諾条件により本文は2012-03-01に公開
URI: http://hdl.handle.net/2433/138598
PubMed ID: 21412040
出現コレクション:Vol.57 No.2

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。